Zyngenia
Pioneering next-gen biotherapeutics with innovative antibody-derived drugs for multi-target applications.
General Information
BounceWatch is an independent company data service, not affiliated with Zyngenia. To contact Zyngenia, visit zyngenia.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Zyngenia compare?
A PDF of Zyngenia and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Zyngenia soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
About Zyngenia
Business keywords: biotherapeutics, antibody-derived drugs, next-generation drugs, Zybody, proprietary technology, biologic therapies, drug development, multi-target applications, innovation, pharmaceuticals
Funding Rounds & Investors (1)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series A | $25.00M | 1 |
|
09 Sep 2010 |
Zyngenia Alternatives & Competitors
View All Alternatives
Innovative biotechnology driving advanced biotherapeutics with enhanced efficacy and reduced side-ef...
Combining innovative science, leading technology, and unmatched know-how to create novel medicines.
Our mission is the golden triangle of healthcare: safety, effectiveness and accessibility. Most heal...
FAQ About Zyngenia
Source: BounceWatch company record for Zyngenia, https://bouncewatch.com/company/zyngenia, updated 27 December 2024. When citing, please name BounceWatch and link this page.
